Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti-obesity-diabetes actions of (Pro3)GIP.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples